Chronic Kidney Disease and Risk of Atrial Fibrillation and Heart Failure in General Population-Based Cohorts: The BiomarCaRE Project
Open Access
- 26 November 2021
- journal article
- research article
- Published by Oxford University Press (OUP) in ESC Heart Failure
- Vol. 9 (1) , 57-65
Abstract
Aims Chronic kidney disease (CKD) has a complicated relationship with the heart, leading to many adverse outcomes. The aim of this study was to evaluate the relationship between CKD and the incidence of atrial fibrillation (AF) and heart failure (HF) along with mortality as a competing risk in general population cohorts. We also included an assessment of baseline biomarkers of inflammation, myocardial injury, and left ventricular dysfunction with risk of AF and HF, respectively, to shed light on the potential underlying pathophysiology. Methods and results This study was conducted within the BiomarCaRE project using harmonized data from 12 European population-based cohorts (n = 48 518 participants). Renal function was assessed by glomerular filtration rate estimated using the combined Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation with standardized serum creatinine (Cr) and non-standardized serum cystatin C (CysC). Incidence of AF and HF respectively, during a median follow-up of 8 years was recorded. Cox proportional hazards models were used to determine hazard ratios (HRs) for the incidence of AF and HF in CKD and the competing risk of mortality after adjustment for covariates. The mean age at baseline was 51.4 (standard deviation 12.1) years, 49% were men. Overall, 4.3% of subjects had CKD at baseline. The rate for AF was 3.8 per 1000 person-years during follow-up. The HR for AF in patients with CKD compared with patients without CKD was 1.28 (95% confidence interval 1.07–1.54) after adjustment for covariates. The rate for incident HF was 4.1 per 1000 person-years and the HR of CKD for HF was 1.71 (95% confidence interval 1.45–2.01. In subjects with CKD, N-terminal-pro-brain natriuretic peptide (NT-proBNP) showed an association with AF, whereas NT-proBNP and C-reactive protein were associated with HF. Conclusions Chronic kidney disease is an independent risk factor for subsequent AF and is even more closely associated with HF. In these relatively young participants with CKD, NT-proBNP was strongly associated with subsequent risk of AF. For HF, in addition, elevated levels of hs-C-reactive protein at baseline were related to incident events.Keywords
Funding Information
- 7th Framework Programme Collaborative Project (HEALTH-F2-2011-278913)
- 7th Framework Programme Collaborative Project (HEALTH-F4-2007-201413)
- 7th Framework Programme Collaborative Project (HEALTH-F3-2010-242244)
- Finnish Foundation for Cardiovascular Research
- Abbott Diagnostics
- German Center of Cardiovascular Research (81Z1710101)
- Medical Research Council (80983)
- Horizon 2020 (825903)
- Horizon 2020 (847770)
- Fifth Framework Programme (QLG2-CT-2002-01254)
- MORGAM (BMH4-CT98-3183)
- Sydäntutkimussäätiö
- Abbott Diagnostics
- Medical Research Council (80983)
- Horizon 2020 Framework Programme (825903)
- Horizon 2020 Framework Programme (847770)
- Fifth Framework Programme (QLG2‐CT‐2002‐01254)
This publication has 16 references indexed in Scilit:
- Sex Differences and Similarities in Atrial Fibrillation Epidemiology, Risk Factors, and Mortality in Community CohortsCirculation, 2017
- Interpreting Cardiac Biomarkers in the Setting of Chronic Kidney DiseaseClinical Chemistry, 2017
- Heart failure and kidney dysfunction: epidemiology, mechanisms and managementNature Reviews Nephrology, 2016
- 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failureEuropean Heart Journal, 2016
- Prospective National Study of the Prevalence, Incidence, Management and Outcome of a Large Contemporary Cohort of Patients With Incident Non‐Valvular Atrial FibrillationJournal of the American Heart Association, 2015
- BiomarCaRE: rationale and design of the European BiomarCaRE project including 300,000 participants from 13 European countriesEuropean Journal of Epidemiology, 2014
- Atrial Fibrillation, Stroke Risk, and Warfarin Therapy RevisitedStroke, 2013
- Cystatin C versus Creatinine in Determining Risk Based on Kidney FunctionNew England Journal of Medicine, 2013
- Expressing the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) Cystatin C Equations for Estimating GFR With Standardized Serum Cystatin C ValuesAmerican Journal of Kidney Diseases, 2011
- MORGAM (an international pooling of cardiovascular cohorts)International Journal of Epidemiology, 2004